Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients with Essential Hypertension
Sponsor: Yuhan Corporation
Summary
This study is to develop a predictive model for cardiocerebrovascular risk factors in elderly patients with essential hypertension with Telmisartan, Amlodipine, and Chlorthalidone Fixed-Dose Combination.
Official title: A Prospective Long-term Cohort Study to Identify the Predictive Model of Cardiocerebrovascular Risk Factors in Elderly Patients with More Than Three Antihypertensive Agents in Patients with Essential Hypertension in Korea
Key Details
Gender
All
Age Range
65 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1219
Start Date
2022-06-08
Completion Date
2027-03-31
Last Updated
2024-11-19
Healthy Volunteers
No
Conditions
Interventions
Telmisartan/Amlodipine/Chlorthalidone(Truset)
Telmisartan/Amlodipine/Chlorthalidone 40/5/12.5 mg or Telmisartan/Amlodipine/Chlorthalidone 80/5/12.5 mg or Telmisartan/Amlodipine/Chlorthalidone 80/5/25 mg
Locations (5)
Busan Veterans Hospital
Busan, South Korea
Daegu Veterans Hospital
Daegu, South Korea
Gwangju Veterans Hospital
Gwangju, South Korea
Konkuk University Medical Center
Seoul, South Korea
Veterans Health Service Medical Center
Seoul, South Korea